catalog number :
MBS624304
products full name :
IRS-1, phosphorylated (Tyr612) (Insulin Receptor Substrate 1)
products short name :
[IRS-1]
products name syn :
[Anti -IRS-1, phosphorylated (Tyr612) (Insulin Receptor Substrate 1)]
other names :
[insulin receptor substrate 1; Insulin receptor substrate 1; insulin receptor substrate 1; IRS-1; OTTHUMP00000164234; insulin receptor substrate 1]
other gene names :
[IRS1; IRS1; HIRS-1]
uniprot entry name :
IRS1_HUMAN
specificity :
Recognizes human IRS-1 when phosphorylated at Tyr612
purity :
Affinity Purified. Purified by immunoaffinity chromatography.
form :
Supplied as a liquid in PBS, pH 7.3, 0.1% BSA, 0.05% sodium azide, 50% glycerol.
concentration :
0.25 mg/mL
storage stability :
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
tested application :
Flow Cytometry (FC), Western Blot (WB), Immunohistochemistry (IHC). Other applications not tested.
app notes :
Recommended Dilution:. Immunohistochemistry (Paraffin): 1:10-1:100 . Flow Cytometry: 3-5ug/million cells. Optimal dilutions to be determined by the researcher.
image1 heading :
Western Blot (WB)
image2 heading :
Immunohistochemistry (IHC)
image3 heading :
Flow Cytometry (FC/FACS)
other info1 :
Immunogen: Synthetic phosphopeptide derived from a region of human IRS-1 that contains tyrosine 612. Species sequence homology: rat, chicken. Positive Control: CHO-T cells transiently transfected with human IRS-1
products categories :
Antibodies; Abs to Protein Kinase Substrates
products description :
Insulin receptor substrates (IRS) are responsible for several insulin related activities, such as glucose homeostasis, cell growth, cell transformation, apoptosis and insulin signal transduction. Serine/threonine phosphorylation of IRS-1 has been demonstrated to be a negative regulator of insulin signaling and is responsible for its degradation, although IRS-1 degradation pathways are not well understood. IRS-1 has also been shown to be constitutively activated in cancers such as breast cancer, Wilm"e;s tumors, and adrenal cortical carcinomas, thus making IRS-1 phosphorylation and subsequent degradation an attractive therapeutic option. To date there have been four subtypes identified: IRS-1,2,3, and 4, with IRS-1 being widely expressed.
ncbi acc num :
NP_005535.1
ncbi gb acc num :
NM_005544.2
ncbi pathways :
Adipocytokine Signaling Pathway (83093); Adipocytokine Signaling Pathway (505); Adipogenesis Pathway (198832); Aldosterone-regulated Sodium Reabsorption Pathway (130626); Aldosterone-regulated Sodium Reabsorption Pathway (130590); Alpha6-Beta4 Integrin Signaling Pathway (198807); Downstream Signaling Of Activated FGFR Pathway (160957); EPO Receptor Signaling Pathway (198882); IGF1 Pathway (137992); IL-2 Signaling Pathway (198885)
ncbi summary :
This gene encodes a protein which is phosphorylated by insulin receptor tyrosine kinase. Mutations in this gene are associated with type II diabetes and susceptibility to insulin resistance. [provided by RefSeq]
uniprot summary :
IRS1: an adaptor protein that is one of the major substrates of the insulin receptor kinase. Contains multiple tyrosine phosphorylation motifs that serve as docking sites for SH2-domain-containing proteins including phosphatidylinositol 3-kinase p85 subunit and GRB-2. Phosphorylated on ser/thr residues by kinases including JNK and IKK. Protein type: Motility/polarity/chemotaxis; Adaptor/scaffold. Chromosomal Location of Human Ortholog: 2q36. Cellular Component: intracellular membrane-bound organelle; cytoplasm; plasma membrane; caveola; nucleus; cytosol. Molecular Function: insulin-like growth factor receptor binding; protein binding; signal transducer activity; protein kinase C binding; phosphoinositide 3-kinase binding; SH2 domain binding; transmembrane receptor protein tyrosine kinase adaptor protein activity; insulin receptor binding. Biological Process: response to peptide hormone stimulus; phosphoinositide 3-kinase cascade; nerve growth factor receptor signaling pathway; positive regulation of glycogen biosynthetic process; negative regulation of insulin receptor signaling pathway; signal transduction; glucose homeostasis; response to insulin stimulus; negative regulation of insulin secretion; positive regulation of glucose import; mammary gland development; positive regulation of mesenchymal cell proliferation; positive regulation of cell proliferation; protein kinase B signaling cascade; epidermal growth factor receptor signaling pathway; phosphoinositide-mediated signaling; fibroblast growth factor receptor signaling pathway; positive regulation of phosphoinositide 3-kinase activity; positive regulation of fatty acid beta-oxidation; insulin-like growth factor receptor signaling pathway; cellular response to insulin stimulus; regulation of gene expression; insulin receptor signaling pathway; innate immune response; positive regulation of insulin receptor signaling pathway; lipid catabolic process; positive regulation of cell migration. Disease: Diabetes Mellitus, Noninsulin-dependent